Metagenomi raises $175m in Series B round to develop treatment pipeline
With the latest funding round, the genetic medicines company has raised a total of $300m.
News
Latest in
News
FDA issues complete response letter for Merck’s chronic cough treatment
The regulatory agency sought further data linked to the measurement of efficacy.
FDA limits usage of Lilly and Regeneron’s monoclonal antibodies for Covid-19
The move comes after data showed these therapies are highly unlikely to be active against the Omicron variant.
Novavax Covid-19 vaccine to be rolled out in Australia from next month
Australia’s health minister said Novavax’s coronavirus jab, Nuvaxovid, should be available from February 21.
By
FDA expands approval for AbbVie’s Skyrizi for active psoriatic arthritis
The FDA approval is based on data from two Skyrizi Phase III trials, KEEPsAKE-1 and KEEPsAKE-2.
FDA issues complete response letter to BLA for Pfizer-OPKO’s somatrogon
Somatrogon is a long-acting recombinant human growth hormone administered once weekly.
Gilead’s Veklury obtains FDA approval to treat Covid-19 outpatients
The authorised dosage is daily intravenous doses of Veklury to be administered for three consecutive days.
Covid-19 update: Annual vaccine preferable to booster shots – Pfizer
Global: The global Covid death toll has passed 5.5 million, with a figure of 5,596,595 according to researchers at Johns…